Latest Diamyd Medical News & Updates

See the latest news and media coverage for Diamyd Medical. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Diamyd Medical

Clinical-stage diabetes therapy developer

diamyd.com
Headquarters
Stockholm, Sweden
Company type
Public company
Number of employees
10–70

Last updated

Latest news about Diamyd Medical

In short: Diamyd Medical halted its Phase 3 DIAGNODE-3 trial due to lack of efficacy, leading to a stock collapse and a transition to new leadership.

Company announcements

  • Diamyd Medical

    Diamyd Medical strengthens manufacturing position

    Received positive feedback from the Medical Products Agency and expects GMP certificate soon. Milestone for Umeå facility.

  • Diamyd Medical

    Diamyd Medical’s new CEO outlines next steps

    Anders Essen-Möller discusses partnership evaluations and future development plans. Published May 4, 2026.

  • Diamyd Medical

    Diamyd Medical announces leadership changes

    Anders Essen-Möller is appointed CEO and Erik Nerpin as Chairman of the Board. Ulf Hannelius leaves the CEO role.

  • Diamyd Medical

    Diamyd Medical announces management changes

    CEO Ulf Hannelius steps down after failed study. Anders Essen-Möller becomes executive chairman. Strategic review ongoing.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Diamyd Medical

Track Diamyd Medical and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Diamyd Medical competitors & trending companies

Browse news for competitors to Diamyd Medical and other trending companies.